SecBot SecBot
SECBOTREPLAY Home › Report › KALV

KALV · Seven executives at KalVista Pharmaceuticals, including the CEO, CFO,…

KalVista Pharmaceuticals, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Seven executives at KalVista Pharmaceuticals, including the CEO, CFO, CMO, CDO, and CCO, exercised stock options and sold shares in the open market over a 7-day period. The total value of shares sold was approximately $396,600, with all sales occurring at $15.5668 per share. The transactions appear to be part of a coordinated post-exercise selling activity following option exercises.

  • CEO Palleiko sold 10,034 shares for $156,197; exercised 23,250 shares prior to sale
  • All five C-suite executives exercised in-the-money stock options between Feb 21–23
  • Total open-market sales: 25,477 shares sold for $396,600 across four days
  • Sales were executed at a uniform price of $15.5668, indicating planned trades

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access